Cara Therapeutics Inc (NASDAQ:CARA)
| 8.24 Delayed Data As of May 27 |  +0.23 / +2.87%Today’s Change | 7.40 Today|||52-Week Range 18.93 | -32.35% Year-to-Date |
Latest CARA News | Press Releases
No recent news for Cara Therapeutics Inc.
Today’s Trading
| Previous close | 8.01 |
| Today’s open | 7.96 |
| Day’s range | 7.95 - 8.29 |
| Volume | 19,567 |
| Average volume (3 months) | 624,261 |
| Market cap | $465.2M |
Data as of 4:00pm ET, 05/27/2022
Growth & Valuation
| Earnings growth (last year) | -1,082.98% |
| Earnings growth (this year) | +27.23% |
| Earnings growth (next 5 years) | -66.83% |
| Revenue growth (last year) | -82.95% |
| P/E ratio | NM |
| Price/Sales | 26.83 |
| Price/Book | 2.04 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| VXRTVaxart Inc | +0.32 | +9.41% |
| ---- | ||
| BNGOBionano Genomics Inc | +0.22 | +14.38% |
| BCYCBicycle Therapeutics... | +0.92 | +6.13% |
Data as of 4:05pm ET, 05/27/2022
Financials
| Next reporting date | August 9, 2022 |
| EPS forecast (this quarter) | -$0.26 |
| Annual revenue (last year) | $23.0M |
| Annual profit (last year) | -$88.4M |
| Net profit margin | -384.06% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Stamford, Connecticut |
Forecasts
